Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer

BACKGROUND: Sipuleucel-T is a US Food and Drug Administration–approved immunotherapy for asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Its mechanism of action is not fully understood. This prospective trial evaluated the direct immune effects of syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Fong, Lawrence, Carroll, Peter, Weinberg, Vivian, Chan, Stephen, Lewis, Jera, Corman, John, Amling, Christopher L., Stephenson, Robert A., Simko, Jeffrey, Sheikh, Nadeem A., Sims, Robert B., Frohlich, Mark W., Small, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241888/
https://www.ncbi.nlm.nih.gov/pubmed/25255802
http://dx.doi.org/10.1093/jnci/dju268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241888/
https://www.ncbi.nlm.nih.gov/pubmed/25255802
http://dx.doi.org/10.1093/jnci/dju268

Ejemplares similares